Top Markets
Coin of the day
AroCell AB (publ) AroCell AB (publ)

AroCell AB (publ)

AROC
Pozycja w akcjach #31792
AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on... AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on the surveillance of various cancerous conditions, such as hematological malignancies, breast cancer, and other solid tumors. The company develops, produces, and markets its flagship product, AroCell TK 210 ELISA, an immunoassay kit designed for measuring Thymidine Kinase 1 levels in human blood. Additionally, AroCell provides TUBEX TF, a rapid bacteriological test for the detection of typhoid fever. Founded in 2000, the firm was originally known as Xi Bao Research AB, adopting its current name, AroCell AB (publ), in 2006. It maintains its headquarters in Uppsala, Sweden.
Cena akcji
$0.05234265
Ostatnia synchronizacja: 2025-06-23
Kapitalizacja rynkowa
$12.06M
Zmiana (1 dzień)
-3.01%
Zmiana (1 rok)
0.00%
Kraj
SE
Handel AroCell AB (publ) (AROC)

Kategoria

Historia stopy dywidendy dla AroCell AB (publ) (AROC)
Stopa dywidendy (TTM) dla AroCell AB (publ) (symbol akcji: AROC) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla AroCell AB (publ) (AROC) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji